Please login to the form below

Mission Therapeutics

This page shows the latest Mission Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Halozyme faces late-stage pancreatic cancer drug failure, cuts 55% of jobs

Halozyme Therapeutics has stopped its pivotal phase 3 study investigating its lead pancreatic cancer drug – and has announced a major restructuring of its workforce that has resulted in a 55% reduction ... Our mission now is to transition our strategy

Latest news

Biomedical Catalyst funding 'must continue', says BIA

macular degeneration (AMD), almost £3m for a Kings College London research team developing a T cell therapy for Crohn's disease and £1.9m for Cambridge start-up MISSION Therapeutics to
GSK forms alliance with Epizyme

The therapeutics would work by controlling the pathways of gene expression that contribute to diseases. ... Dr Robert Gould, CEO and president of Epizyme, said: "Epizyme's mission is to develop personalised therapeutics for genetically-defined patients

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Can protein degraders unlock ‘undruggable’ drug targets?

1 trial of its lead candidate ARV-110 in prostate cancer earlier this year, ahead of rival biotechs such as C4 Therapeutics and Kymera Therapeutics as well as big pharma firms ... Other approaches are also in early-stage testing. Deubiquitylating (DUB)
25 Women Leaders in UK Healthcare

Before she joined Crescendo, she held industry and corporate finance roles with private and listed SMEs, including PsiOxus Therapeutics, MISSION Therapeutics, OrthoMimetics and Cytomyx. ... Also a great contributor to the HBA at both the EU and UK level,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Dr Colin Goddard appointed chairman at Mission Therapeutics

Mission Therapeutics has appointed Dr Colin Goddard as its non-executive chairman, a role he will take up on January 1. ... Meanwhile, Mission Therapeutics' current chairman Dr Michael Moore will continue to sit on the firm's board and move into the
Crescendo Biologics appoints CFO

She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics. ... ambitious plans to create a high value pipeline of differentiated
Mission Therapeutics appoints new chief financial officer

David Luther joins with 25 years healthcare and pharmaceutical experience. Cambridge, UK-based Mission Therapeutics has appointed David Luther as chief financial officer. ... development. Dr Anker Lundemose, CEO of Mission Therapeutics, said: “David's
MISSION appoints Paul Wallace as chief business officer

Cancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer. ... The diversity of assets created is testimony to the rigour of MISSION's screening platform in this critically important, but hitherto difficult, area of drug

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Patient-centricity in improving patient recruitment advertising: This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI: the smart money is on the smart thinking: Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Virtual Engagement At Porterhouse: Reflections on the past few months: A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....